Back to top

Replimune Group (REPL) Gets a Hold from Barclays

Barclays analyst Peter Lawson maintained a Hold rating on Replimune Group today and set a price target of $3.00. The company’s shares closed yester...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Replimune Group, Inc. (REPL)